Document is current

Article History

Received: 1 July 2025

Accepted: 21 September 2025

First Online: 9 October 2025

Declarations

:

: JS has served as the principal investigator for clinical trials for which his institution received grants and has received honoraria from AbbVie, Gilead, Janssen, Merck, Theratechnologies, and ViiV Healthcare. APB and DM are employees of ViiV Healthcare and own stock in GSK. GH, KM, and AM are employees of Adelphi Real World, which was contracted by ViiV Healthcare for this analysis. GV is an employee of ViiV Healthcare.

: Ethics approval to conduct this study was granted by Western Institutional Review Board (tracking reference, 20224682).

: All participants provided informed consent to participate in surveys and interviews.

: All participants provided signed consent to publish anonymized findings before surveys and interviews were conducted.

: Anonymized individual participant data and study documents can be requested for further research from .

: GH, KM, AM, DM, and GV contributed to the conception of the study. APB, GH, KM, AM, DM, and GV contributed to the design of the study. JS, GH, KM, AM, and DM contributed to the acquisition of data. APB, GH, KM, AM, DM, and GV contributed to the analysis of data. All authors contributed to the interpretation of data, drafting the manuscript, and critically revising the manuscript for important intellectual content. All authors approved the manuscript for publication.